-
Phase 2 trial launches of CD46-targeting ADC in mCRPC
24 Sep 2025 22:46 GMT
… which can include abiraterone acetate (Zytiga), enzalutamide (Xtandi), apalutamide … study or discontinued the trial.
“We anticipate … significantly higher on-treatment frequency of circulating … an immune-modulating antibody-drug conjugate targeting CD46, …
-
Prostate hell: Experts, survivors speak about causes, symptoms, diagnosis and treatment
23 Sep 2025 03:02 GMT
… of God that the doctor discovered this thing very … What are the causes and remedies?
Dr Christian Agbo, a … using anti androgen hormonal treatment options like Casodex, Zytiga, Flutamide, and … abuse, go for routine medical checkups and do regular exercises …
-
<![CDATA[Navigating ARANOTE Trial Findings and Insurance for Prostate Cancer]]>
16 Sep 2025 01:00 GMT
… Medical Center, reviewed the results of the phase 3 ARANOTE trial … approach for discussing the various treatment options with newly diagnosed … least have them hear the drug names, we give them … [Xtandi], or even abiraterone [Zytiga] because that's the …
-
ESMO 2025 preview: Key late-breaking abstracts in genitourinary oncology
25 Sep 2025 19:28 GMT
… the European Society for Medical Oncology (ESMO) Congress has … (Zejula) to abiraterone acetate (Zytiga) plus prednisone (AAP) led … the FDA’s approval of the drug for the treatment of … . IMvigor011 bladder cancer trial achieves positive results, with Signatera …
-
Prostate Cancer Pipeline Outlook 2025 - Investigational Therapies, Clinical Trials, Drugs And Companies, Medication, By Phase, By ROA, By MOA Delveinsight
29 Aug 2025 21:11 GMT
… trials. Recent updates include FDA fast-track designations, trial … HengRui Medicine';s Fuzuloparib … Syntrix Pharmaceuticals
Promontory Therapeutics
Xencor
Taiho Pharmaceutical
Madison Vaccines
… prostate cancer treatments, visit @ Prostate Cancer Drugs and …
-
Dr Qin on the Design of the HARMONY Trial of Niraparib-Based Therapy in mHSPC
29 Aug 2025 00:02 GMT
… acetate (Zytiga) and prednisone in patients with treatment-naive … Qin began. This trial structure allows treatment to be tailored … Prior pivotal phase 3 trials leading to current standard- … data to inform precision medicine approaches in prostate cancer …
-
Applying Recent Trial Data to mHSPC Clinical Decision-Making
19 Aug 2025 22:47 GMT
… Southwestern Medical Center, moderated a discussion on these treatments. … Zhang reviewed the regimens approved in mHSPC, including abiraterone (Zytiga … the timeline for mHSPC trials in terms of … [NCT02446405] was a trial mostly in Australia and …
-
Pfizer and J&J face new heat as Bayer’s Nubeqa racks up FDA and Korea wins in prostate cancer
21 Aug 2025 01:10 GMT
… cancer treatment, pitching the androgen receptor inhibitor as a backbone drug … share from rivals.
The FDA’s June nod for metastatic … blinded trials, he added, it was “hard even for doctors to … have the head start: Zytiga, selectively reimbursed since 2021 and …
-
Darolutamide Doublet Is Redefining Treatment Decision-Making for mCSPC
20 Aug 2025 20:40 GMT
… medicine at Harvard Medical School.
OncLive: How did the ARANOTE trial … cancer has been treatment intensification as initial … with ADT plus abiraterone (Zytiga) with or without … www.fda.gov/drugs/;resources-information-approved-drugs/fda-approves- …
-
Profound Medical Corp. (NASDAQ:PROF) Q2 2025 Earnings Call Transcript
16 Aug 2025 12:51 GMT
… a Phase II trial evaluating TULSA for the treatment of men … compatibility and any potential remediation that may need to … trials that might be relevant in the peer-reviewed medical … downstream into localized disease, ZYTIGA and XTANDI, specifically the …